ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
182 hedge funds and large institutions have $1.41B invested in Array Biopharma Inc in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
182
Holding in Top 10
3
Calls
$24.3M
Puts
$24.2M
Top Buyers
| 1 | +$27.9M | |
| 2 | +$27.6M | |
| 3 | +$24.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22M |
| 5 |
Morgan Stanley
New York
|
+$18M |
Top Sellers
| 1 | -$39.7M | |
| 2 | -$17.8M | |
| 3 | -$17.7M | |
| 4 |
Two Sigma Investments
New York
|
-$14.2M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$12.3M |